GGrantIndex
Sort

82,697 grants matching vaccine development

Innovations in Functional B Cell Epitope Discovery for Lyme Disease

$1,809,220
Nicholas Mantis · Nysdoh/Health Research, Inc. · N01 · FY2024 · AI

Non-Human Primate Core

$1,809,034
Kathryn Foulds · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI

Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease

$1,808,328
Cynthia Nau Cornelissen · Georgia State University · U19 · FY2023 · AI

Innate immune regulation of inflammation and adaptive immunity

$1,807,133
Anthony L. Defranco · University Of California, San Francisco · P01 · FY2010 · AI

DNA Vaccines

$1,806,442
George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Respiratory Immunity Against Agents of Bioterrorism

$1,806,194
Steven B. Mizel · Wake Forest University Health Sciences · P01 · FY2008 · AI

Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease

$1,806,071
Cynthia Nau Cornelissen · Georgia State University · U19 · FY2022 · AI

Novel approaches for vaccine design

$1,805,982
Michel C Nussenzweig · Rockefeller University · P01 · FY2011 · AI

HIV VACCINE CLINICAL TRIALS UNIT

$1,805,507
University Of Rochester · U01 · FY2002 · AI

mAbs and vaccines against SARS CoV-2

$1,805,411
Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Multiscale Analysis of Immune Responses

$1,805,294
Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Novel approaches for vaccine design

$1,805,259
Michel C Nussenzweig · Rockefeller University · P01 · FY2012 · AI

Innate immune regulation of inflammation and adaptive immunity

$1,805,168
Anthony L. Defranco · University Of California, San Francisco · P01 · FY2008 · AI

improving outcomes after stem cell transplantation

$1,805,115
Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL

Immunotherapy to prevent drug-resistant tuberculosis

$1,804,739
Rhea N Coler · Seattle Children'S Hospital · R01 · FY2020 · AI

WANPRC MACACA NEMESTRINA SPF BREEDING COLONY

$1,804,687
David M Anderson · University Of Washington · U42 · FY2010 · RR

WaNPRC Macaca nemestrina SPF Breeding Colony

$1,804,687
David M Anderson · University Of Washington · U42 · FY2010 · RR

Genome-wide hypermutation and structural instability

$1,804,408
Dmitry Gordenin · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES

California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations

$1,803,929
Joel Palefsky · University Of California, San Francisco · U54 · FY2023 · CA

Expansion and targeted maturation of germline HIV-1 bNAb-associated BCRs

$1,803,472
Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · P01 · FY2020 · AI

Toward a Universal Influenza Virus Vaccine

$1,803,471
Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2020 · AI

Continued Development of a Recombinant Vaccine (RivaxTM) against Ricin Toxin

$1,802,850
Robert Newton Brey · Soligenix, Inc. · U01 · FY2007 · AI

Role of the microbiota in immunity

$1,802,530
Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Toward a Universal Influenza Virus Vaccine

$1,802,510
Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2018 · AI

Sample Collection and General Screening Protocols

$1,801,500
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI